about
Macrophage Migration Inhibitory Factor in Clinical Kidney DiseaseCD74 in Kidney DiseaseMolecular mechanisms of diabetic kidney diseaseTWEAK promotes peritoneal inflammationHSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implicationsTNF superfamily: a growing saga of kidney injury modulators.Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbiditiesMacrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infectionInflammation in diabetic kidney diseaseThe outcome of renal ischemia-reperfusion injury is unchanged in AMPK-β1 deficient mice.Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.Laser therapy in metabolic syndrome-related kidney injury.TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α.Transcriptional profiling reveals progeroid Ercc1(-/Δ) mice as a model system for glomerular aging.Cinnabar-induced subchronic renal injury is associated with increased apoptosis in ratsOsteoprotegerin in exosome-like vesicles from human cultured tubular cells and urineAttenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factorFabry disease: the many faces of a single disorder.Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritisMacrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1-p38-Xanthine Oxidoreductase-Dependent Cigarette Smoke-Induced Apoptosis.Macrophage Migration Inhibitory Factor Mediates Proliferative GN via CD74Macrophage Migration Inhibitor Factor Upregulates MCP-1 Expression in an Autocrine Manner in Hepatocytes during Acute Mouse Liver Injury.Fibrosis: a key feature of Fabry disease with potential therapeutic implicationsChemokine profile in the sera and urine of patients with schistosomal glomerulopathy.The role of metabolic and haemodynamic factors in podocyte injury in diabetes.Acute and sustained actions of hyperglycaemia on endothelial and glomerular barrier permeability.Targeting inflammation in diabetic kidney disease: early clinical trials.Crosstalk between protective autophagy and NF-κB signal in high glucose-induced podocytes.High glucose up-regulates angiotensin II subtype 2 receptors via interferon regulatory factor-1 in proximal tubule epithelial cells.Suppressors of cytokine signaling abrogate diabetic nephropathy.Increased urinary CD80 excretion and podocyturia in Fabry disease.Is it or is it not a pathogenic mutation? Is it or is it not the podocyte?Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation.3,4-DGE is cytotoxic and decreases HSP27/HSPB1 in podocytes.The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury.Defining Phenotypes in Diabetic Nephropathy: a novel approach using a cross-sectional analysis of a single centre cohort.Macrophage migration inhibitory factor as a potential predictor for requirement of renal replacement therapy after orthotopic liver transplantation.MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms.Inhibition of macrophage migration inhibitory factor reduces diabetic nephropathy in type II diabetes mice.
P2860
Q26767479-F460BBDA-A865-49C3-A65E-2BDD1167C2DFQ26781254-DC9BB605-2979-4285-879C-A3EF6EB2E875Q27003963-A51FAC22-FF90-4665-B15D-CEF856E33725Q27318227-09968509-FC28-4207-B174-640B41BC599DQ28578531-7E6A91D8-DE39-4FE8-9386-EFC417A1130BQ30239808-ED34249D-4C35-45F3-B439-B36441B82ECCQ30479123-13CB65BC-C4F8-44AB-AA88-6F26886FE795Q33651788-DA66BFE7-25C1-4CE7-9D5D-C2C8C6AAF679Q33715838-10737FA0-1575-4668-B422-8E4527A49E83Q34023543-579F0728-84E0-4DC1-9BAF-9DF167689B09Q34130765-8D23FF96-186E-4BE2-B28F-D84293C5D411Q34358320-5C61171A-C412-4C1C-BDC2-44459886304DQ34566817-F76BFF8B-1E52-4614-AEA5-C64411AF48EFQ34788604-B8B43FAE-9AFB-402E-8016-06FA577CF31EQ34943024-870A54DA-082A-41EA-8B86-2930E9D5592AQ34988745-58646280-06B4-4800-BCAF-F392C7DA50C3Q34994210-6A7B0326-3EEE-4F91-8416-865FCE5FA278Q35391070-DEAEB185-91ED-4BB7-81C0-A37C0FA3A039Q35608422-EFA5CACC-CCD9-44FC-B8EE-1CA6EB0C5ECEQ36520641-CFF818A3-E652-409F-BE44-0D96B82A8DB0Q36765952-E02567F9-CC8E-4D18-95FA-B6FFDA7303D2Q36944652-139ED7B9-0B46-43B2-A726-3F83701C13E5Q36980410-B3152014-6602-4C7A-8231-03311C34F54DQ37113004-B34EFE21-476A-419A-9921-2AFD360A446CQ37456159-4E7ECC46-3E1B-4A01-BF67-BBC312B4B87CQ37838893-3C39B470-B999-454D-B3EB-8E206E4B0704Q37910988-3D36B0D0-5C04-47D3-B776-82B348D784AAQ38857166-7B252BF9-8983-4E3F-8D5B-5AA3444D3270Q38981875-3EABDE4B-0B81-4FD2-9938-F009EC5B7030Q39685731-5777AF4C-E801-416F-9C49-A234F2EBFEACQ39735007-685711A7-46B5-4FB6-98F4-0A4E2E8173F8Q41452180-1321738A-C1BF-476B-A025-33939518F71FQ41861331-8E7DD40B-A383-4C19-81DC-0A1A633D7419Q43230114-560BA0F3-0E87-48BC-BD0A-8A252A1E4C74Q44979188-38C02C9B-C585-40EC-B714-65C677FCC520Q47159298-4D7BDE80-3FE2-4BD1-AE32-E2BCB66DBC12Q47195052-779FC73C-D911-4DDA-99A2-32946F5E09CCQ47737276-AC051A90-7234-4BD4-B9B1-BABFA638326BQ47882270-90898DBC-2EA7-4712-98A0-29A23D07990DQ51072366-DB1B5F07-FAA8-476A-B833-C9D35C869278
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The MIF receptor CD74 in diabetic podocyte injury.
@en
The MIF receptor CD74 in diabetic podocyte injury.
@nl
type
label
The MIF receptor CD74 in diabetic podocyte injury.
@en
The MIF receptor CD74 in diabetic podocyte injury.
@nl
prefLabel
The MIF receptor CD74 in diabetic podocyte injury.
@en
The MIF receptor CD74 in diabetic podocyte injury.
@nl
P2093
P2860
P50
P356
P1476
The MIF receptor CD74 in diabetic podocyte injury.
@en
P2093
Alberto Ortiz
Ana Belen Sanz
Claudio Aros
Deborah Mattinzoli
Eero Mervaala
Harry Holthofer
Jesus Egido
Jose Luis Martin-Ventura
Kevin V Lemley
Maria Dolores Sanchez-Niño
P2860
P304
P356
10.1681/ASN.2008020194
P577
2008-10-08T00:00:00Z